TP53 status determines clinical significance of ERBB2 expression in ovarian cancer

ERBB2 expression has been found in 19 to 44% of ovarian carcinomas; however, its predictive value has not been demonstrated, and trastuzumab has not found clinical application in ovarian cancer patients. We evaluated clinical significance of ERBB2 expression in relation to TP53 accumulation in ovari...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Kupryjańczyk, J, Mądry, R, Plisiecka-Hałasa, J, Bar, J, Kraszewska, E, Ziółkowska, I, Timorek, A, Stelmachów, J, Emerich, J, Jędryka, M, Płużańska, A, Rzepka-Górska, I, Urbański, K, Zieliński, J, Markowska, J
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Nature Publishing Group 2004
Konular:
Molecular and Cellular Pathology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2409772/
https://ncbi.nlm.nih.gov/pubmed/15545967
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6602238
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller